Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: rationale and design of first-in-human randomised controlled trial di Richard J Nowak, Samantha G Brew, Molly Frey, Derrick P McCarthy, Adam Elhofy

Testo

US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization di Richard J. Nowak, Ali A. Habib, Andrew J. Klink, Srikanth Muppidi, Anju Parthan, S. Chloe Sader, Alexandrina Balanean, Ajeet Gajra, James F. Howard, ELEVATE Study Group

Testo

Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination di Marc Garbey, Marc Garbey, Marc Garbey, Quentin Lesport, Quentin Lesport, Helen Girma, Gülşen Öztosun, Mohammed Abu-Rub, Amanda C. Guidon, Vern Juel, Richard J. Nowak, Betty Soliven, Inmaculada Aban, Henry J. Kaminski

Testo